The alarming rate at which breast cancer is increasing among women has incited a global health concern. A recent survey by BCRF states that approximately 685,000 people lost their lives in 2020 due to this invasive disease, making it one of the leading causes of death among females.

However, there are consecutive and widespread efforts to create awareness about symptoms of breast cancer and how adopting a healthy lifestyle lowers the risk of developing said cancer. Which combined with screening programs, reduces the risk of late detection and enhances survival chances drastically.

It is quite comforting to know that the entire community is giving a fillip to the verve of brainstorming approaches that could abate the occurrence of breast cancer. In addition, a lot of technological advancement has taken place over the past decade, which has further expedited the screening, diagnosis and treatment of life-threatening diseases like cancer.

A Stockholm-based health-tech firm, Thermaiscan Technology AB, is innovating within the predictive medicine field, combining AI with thermal technology. Inspired by Hippocrates, often referred to as the father of modern medicine, the team has adopted the age-old theory of using heat. Heat, or lack thereof, has long been used as an indicator for finding disease.

Thermaiscan’s prime focus is to solve the global problem with late detection of breast cancer development. Late detection is the leading cause of breast cancer related deaths. The Thermaiscan Breast Cancer Pre-screening solution uses a smartphone with thermal sensors and AI models that performs the analysis of the thermal images. If any abnormality is detected, the patient shall be conferred to medical specialist care. Early detection can save lives as well as lowering the cost for care.

The tool empowers first-line contact physicians, non-specialists and remote doctors in their mission to provide professional care. Healthcare personnel can easily perform thermal screenings according to the Thermaiscan protocol with the smartphone. They will then receive the AI analysis, which provides valuable information about the health status in the chest of women. The pocket-sized, non-invasive, non-toxic, and cost-efficient screening tool is designed to perform comfortable breast cancer pre-screening on women of all ages.

There is currently an unfair distribution of specialist and breast cancer screening tools in many countries. The fact is that many women do not even have access to standard breast cancer screenings, especially women in rural areas and those without universal health coverage.

Thermaiscan Pre-screening can be life saving for these women as it can be used in remote settings and in primary healthcare.

Women that want to be proactive can easily take advantage of the latest state-of-the-art technology. Tools like the Thermaiscan Pre-screening can work as a complementary tool to already existing screening processes. It is not intended to replace or compete with mammography, rather it will provide more data to specialists in order to detect early stage breast cancer.

Thermaiscan Technology AB is part of the India-Sweden Healthcare Innovation Centre, established to develop an ecosystem of open innovation for start-ups and healthcare delivery stakeholders. Through the Centre, Thermaiscan Technology is now also a part of A.Catalyst network – an interconnected and dynamic global network of more than 20 AstraZeneca health innovation hubs, made up of Physical locations and virtual partnerships. The network embodies the commitment to Growth Through Innovation as ‘a catalyst’ to develop new solutions for patients. It aims to address healthcare challenges, increase access to healthcare and scale and showcase patient-enabled innovation through partnerships within the health ecosystem.

The company’s journey has been a buoyant one. Together with AIIMS Jodhpur, India-Sweden Healthcare Innovation Centre (A partnership between India’s premier healthcare institutions AIIMS Delhi, AIIMS Jodhpur and Business Sweden, closely guided by the Ministry of Health (including ICMR) in Sweden and India, along with Knowledge Partner AstraZeneca as well as Technology Partner NASSCOM CoE IoT & AI, A-Catalyst Network, Atal Innovation Mission, AGNIi (Invest India) and StartUp India and others), and many more in the pipeline soon to be unveiled, Thermaiscan is now preparing for what is needed – such as a clinical study – to launch their first product in the market.

Thermaiscan has won prestigious awards, including an Innovation Challenge organized by the India-Sweden Innovation Centre, the Nexer Dream Big challenge and Ignite Master of B2B Collaboration 2021 – Private Sector. To date, Thermaiscan Technology has expanded its presence across Sweden, Armenia, India, Germany, and Singapore. It has established collaboration with

leading institutions like AstraZeneca, Labz.AI, Karolinska Institutet Innovation AB, Business Sweden, Vinnova, ENOX, Almi, Erebouni Medical Center- Breast Unit, and more.

Thermaiscan intends to remain committed to unearthing the true potential of HealthTech and predictive medicine via its technical competence within thermal imaging and AI. The team is looking forward to initiating associations with innovators, leaders, and investors who envisage revolutionizing healthcare for the benefit of society.

Leave a Reply

Your email address will not be published. Required fields are marked *

WordPress Themes